NCT02606032View on ClinicalTrials.gov

Trial of Antimicrobials Versus Placebo in Addition to Fecal Transplant Therapy in Ulcerative Colitis

PHASE2CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

January 31, 2021

Study Completion Date

January 27, 2021

Conditions
Ulcerative Colitis
Interventions
DRUG

Metronidazole

active comparator

DRUG

Doxycycline

active comparator

DRUG

Terbinafine

active comparator

DRUG

Placebo

identical placebos to all antibiotics

Trial Locations (1)

L8N 3Z5

Hamilton Health Sciences / McMaster University, Hamilton

All Listed Sponsors
collaborator

Hamilton Academic Health Sciences Organization

OTHER

lead

Hamilton Health Sciences Corporation

OTHER

NCT02606032 - Trial of Antimicrobials Versus Placebo in Addition to Fecal Transplant Therapy in Ulcerative Colitis | Biotech Hunter | Biotech Hunter